The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks. Drugs (Pharmaceuticals), Alzheimer’s Disease, Brain, Memory, Leqembi (Drug), Clinical Trials, Placebos, Dementia, Prices (Fares, Fees and Rates), Eli Lilly and Company, Biogen Inc, Eisai Co Ltd, Food and Drug Administration, your-feed-science, your-feed-healthcare NYT > Health
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
